ksn.com: Data with topical pravibismane for infected chronic diabetic foot ulcers in first-to-podium research at SAWC Spring/WHS
Data with topical pravibismane for infected chronic diabetic foot ulcers in first-to-podium research at SAWC Spring/WHS
Nasdaq: BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
Business Wire: RION Announces First Patient Dosed in Phase 2 Clinical Study of Purified Exosome Product™ for Diabetic Foot Ulcers
RION Announces First Patient Dosed in Phase 2 Clinical Study of Purified Exosome Product™ for Diabetic Foot Ulcers
Business Insider: VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Monthly Prescribing Reference: Regenerative Tissue Product Designated Breakthrough Therapy for Diabetic Foot Ulcers
Yahoo: Foot Pain + High Blood Sugar? The Early Signs of a Diabetic Foot Ulcer
Foot Pain + High Blood Sugar? The Early Signs of a Diabetic Foot Ulcer
Patients suffering from chronic diabetic foot ulcers (DFUs) could experience at least a fourfold increase in healing over standard of care with 12 weeks of home-based topical wound oxygen (TWO2) ...
News Medical: Study identifies diagnostic aid to accurately predict the recurrence of diabetic foot ulcers
Study identifies diagnostic aid to accurately predict the recurrence of diabetic foot ulcers
Despite being an underrecognized issue in both clinical practice and policy, a recent study found the 3-year recurrence rate for diabetic foot ulcers (DFUs) and the reintervention rate for chronic ...